BiotechTube
Data
Discover
News
Company
Search...
⌘K
Sign in
BiotechTube
Home
/
BioGenCell
/
Sharon Cohen
SC
Sharon Cohen
VP R&D
BioGenCell
Therapeutic Areas
Vascular
Cardiovascular
Neurology
Oncology
Immunology
Regenerative Medicine
BioGenCell Pipeline
Drug
Indication
Phase
BGC101
Chronic Limb‑Threatening Ischemia (CLTI)
Phase 2
BGC10X
Broad Microvascular Unmet Needs
Preclinical
Leadership Team at BioGenCell
YP
Yael Porat, PhD
Founder, CEO & CSTO
MF
Michal Fisher
Chief Business Officer
EP
Eyal Peleg, CPA, MBA
Founder, CFO
View full BioGenCell profile